The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
Abstract
OBJECTIVE: Recent studies suggest the beneficial effects of metformin on glucose metabolism may be microbially mediated. We examined the association of type 2 diabetes, metformin, and gut microbiota in community-dwelling Colombian adults. On the basis of previous research, we hypothesized that metformin is associated with higher levels of short-chain fatty acid (SCFA)–producing and mucin-degrading microbiota. RESEARCH DESIGN AND METHODS: Participants were selected from a larger cohort of 459 participants. The present analyses focus on the 28 participants diagnosed with diabetes—14 taking metformin— and the 84 participants without diabetes who were matched (3-to-1) to participants with diabetes by sex, age, and BMI. We measured demographic information, anthropometry, and blood biochemical parameters and collected fecal samples from which we performed 16S rRNA gene sequencing to analyze the composition and structure of the gut microbiota. RESULTS: We found an association between diabetes and gut microbiota that was modified by metformin use. Compared with participants without diabetes, participants with diabetes taking metformin had higher relative abundance of Akkermansia muciniphila, a microbiota known for mucin degradation, and several gut microbiota known for production of SCFAs, including Butyrivibrio, Bifidobacterium bifidum, Megasphaera, and an operational taxonomic unit of Prevotella. In contrast, compared with participants without diabetes, participants with diabetes not taking metformin had higher relative abundance of Clostridiaceae 02d06 and a distinct operational taxonomic unit of Prevotella and a lower abundance of Enterococcus casseliflavus. CONCLUSIONS: Our results support the hypothesis that metformin shifts gut microbiota composition through the enrichment of mucin-degrading A. muciniphila as well as several SCFA-producing microbiota. Future studies are needed to determine if these shifts mediate metformin’s glycemic and anti-inflammatory properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biguanides/metformin, the first-line therapeutics for T2D, modifies microbiota leading to an increase in A. muciniphila, as well as several SCFA-producing microbiota, favoring an improvement on mucin-producing goblet cells, pro-inflammatory IL-6, and glucose tolerance [304].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [304]
In the citing paper
“In human diabetic individuals, metformin was shown to shift gut microbiota composition to predominantly short-chain fatty-acid producing microbes”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as de la Cuesta-Zuluaga et al. 2017
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 2×
“pairwise tests among groups of participants using the unpaired Wilcoxon rank sum test, and finally uses LDA to estimate the effect size of each differentially abundant OTU (24).”
MethodKozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513 · cited 1×
“Prevotella has been associated with carbohydrate-baseddiets anddegradation of complex polysaccharides (26), whereas E.”
BackgroundCross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · cited 3×
“abundance of Akkermansia muciniphila (11–13), a mucin-degrading bacteria that has been shown to reverse metabolic disorders (1,12).”
BackgroundInfluentialGut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“Given the considerable variation in the microbiota associated with type 2 diabetes and that the gut microbiota of Colombians is different to that of other populations (18), we hypothesized that the microbial taxa involved in the type 2 diabetes dysbiosis of Colombians are different to those observed in Chinese and Eur…”
BackgroundGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851 · cited 1×
“through effects on bile acid secretion (31).”
Cited by
Items 701–731 of 731
Darbandi, M. H., & Dalmacio, L. M. M. (2026) · Acta Biochimica Polonica · doi:10.3389/abp.2026.16199
Therapeutic options for Clostridioides difficile infections
Balázs, V. A. (2023) · Pesci Egyetemi Archivum (University of Pécs)
Modulating gut microbiota in type 2 diabetes mellitus: advances and challenges in precision medicine
Rasmi, M., Krishnamoorthi, R., Akbar, R., Mahalingam, P. U., Arokia, V. A. M., & Thiyagarajan, P. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02650-3
Kotlyarov, A. A., Вячеславовна, У. Т., Дмитриевна, А. Е., Сергеевич, Ф. Н., Kotlyarova, Y., & Геннадьевна, К. С. (2026) · Medicine and Biotechnology · doi:10.15507/3034-6231.002.202601.058-070
Restaurer la fonction bêta pancréatique de la souris leptine déficiente par la chirurgie bariatrique
Amouyal, C. (2019) · theses.fr (ABES) · doi:10.70675/57e90c8dz951az4b06z95cdzc78f34db6015
Développement et caractérisation d’une molécule antinéoplasique ciblant l’AMPK et MELK
Cavazza, E. (2021) · theses.fr (ABES) · doi:10.70675/e5e2f0d1zc511z4f8az9fcfz08497d160992
The Gut–Adipose–Tumor Axis in Obesity-Related Cancer
Feng, J., Huang, Y., Lai, S., Zhao, T., Xie, Y. Q., Zhu, X., Liu, L., Tang, D., & Yan, A. (2026) · Nutrients · doi:10.3390/nu18081230
GUT MICROBIOTA IN CARDIOVASCULAR DISEASES. FROM MECHANISTIC INSIGHTS TO THERAPEUTIC PERSPECTIVES
Majda, A., Sitko, N., Makowska, P., Gontarczyk, J., Laske, A., Sowa, M., Pająk, J., Kucharski, K., Kamosińska, A., Kowal, A., et al. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5403
Antibacterial Properties Of The Diabetic Drug Metformin
Maarouf, L. M. E. A. (2025) · UEA Digital Repository (University of East Anglia)
Azadi, S., Fadaei‐kenarsary, M., Sahebi, K., Baneshi, M., Tajbakhsh, A., Niknahad, H., & Negahdaripour, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119553
Saka, W. A., Oyedokun, P. A., Alade, T. A.-M., Oyeleke, B. T., Oyelaran, A. O., Oyedokun, M. D., Irozuoke, C. A., Olayemi, O. M., Oladepo, S., & Ndako, J. A. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02349-z
Li, J., Ji, J., Ma, X., Xu, Z., Zhou, L., Guan, Y., Ling, X., Jia, X., Xi, B., & Zhao, M. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128569
Modulatory effects of culinary spices on the human gut microbiome in type II diabetes management
Chuphal, B., Kumari, M., & Kumar, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44546-0.00003-7
Zhang, X., Wang, Z., Hu, Y., Yang, M., Jingyu, H., Jia, X., Zhao, W., Liu, X. D., Liu, Z., & Lu, Y. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109333
Zheng, Y., Park, C., Hwang, H., Cho, H., Kim, M., Kim, A., & Kang, I. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109350
Maharana, K. C., Singh, S., Abubakar, M., & Pandey, S. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02537-y
Pengrattanachot, N., Jaruan, O., Promsan, S., Sutthasupha, P., Jaikumkao, K., & Lungkaphin, A. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2026.159761
Chen, M., Li, R., Xiang, Y., Ma, X., Yu, X., Zhao, J., & Ren, D. (2026) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.70969
Ahmed, S., McCollin, S. P., Martí-Carvajal, A. J., Akus, M., Baron, D. W., Razzaq, S. A., Scudder, P. N., Honigsberg, E. J., Nasir, S., Peng, K., et al. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016380
Jóźwik-Szymańska, A., Kostecka, N., Mikula, L., Bogdan-Groszyk, Z., Szredzka, A., Kucharski, J., Makulec, A., Otrębska, K., & Lewandowska, D. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(51).2026.6514
Genetic Variants Involved in Metformin Pharmacokinetics in the Chilean Population
Miranda, J. P., Alberti, G., Pereira, A., Gana, J. C., & Santos, J. L. (2026) · Genes · doi:10.3390/genes17091114
“…and inflammation [6,21], and (g) metformin has been described to alter the intestinal microbiota composition, mainly by promoting an increase in the population of butyrate, propionate, succinate, and mucin-producing bacteria, with a positive hypoglycemic and anti-inflammation effects [22].”
Deepika, D., Bharti, K., Brull, J., Sabuz, Ó., Musengi, Y., & Kumar, V. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1840947
Li, Y., Liu, Y., Chen, Y., Xiang, B., Fu, H., Han, P., Xu, T., Li, Z., Zhang, Y., Yuan, H., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1972983
“Metformin use has been associated with higher A. muciniphila abundance in humans (de la Cuesta-Zuluaga et al., 2017).”
Xie, S.-S., Hu, J., Zhou, W., Ge, X., Luo, Y.-Y., & Liu, Z. (2026) · World Journal of Pediatrics · doi:10.1007/s12519-026-01094-7
Vidal, Y., de la Hoz, S., Santrich, A., Parody, A., Rosero, C., & Peñaloza, E. (2024) · REVISTA UNIMETRO
Unraveling the Gut Microbiota Influence on Arsenic Toxicity and Detoxification
Pothuraju, N., Bhoomgari, R., Annem, R. R., & Naresh, P. (2026) · Indian Journal of Microbiology · doi:10.1007/s12088-026-01584-2
Gudmundsson, P., Cluver, C. A., Sandström, A., Lindström, L., Timpka, S., Hesselman, S., Lilliecreutz, C., Wendel, S. B., von Wowern, E., Lindén, K., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-120993
“18 Furthermore, recent studies in mice 19 and humans 20 21 suggest that gut microbial changes contribute to the effects of metformin.”
Durairaj, K., Gajendhran, B., Manivel, G., Gnanam, H., Swaminathan, K., Mithieux, G., & Velmurugan, G. (2026) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2026.101677
Yoshida, K., Onishi, Y., Kubota, T., Yoshida, Y., Tahara, T., Takase, S., Iwamoto, M., Nakada, R., Aita, H., & Kasuga, M. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70476
“Metformin has been reported to modify the intestinal environment by altering the gut microbiota, 13 – 15 and animal studies have shown that imeglimin monotherapy also induces gut microbiota changes.”
Метформин и микробиота кишечника
Николаевна, Г. И., Ивановна, Р. Т., Станиславовна, С. Т., & Львович, Н. Д. (n.d.) · CyberLeninK (CyberLeninka)
Metadata
- Authors
- de la Cuesta-Zuluaga, J., Mueller, N. T., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S.
- Affiliations
- Vidarium—Nutrition, Health and Wellness Research Center, Grupo Empresarial Nutresa, Medellin, Colombia
- Johns Hopkins University (US)
- Vidarium - Centro de Investigación en Nutrición Salud y Bienestar (CO)
- Dinámica I.P.S.—Especialista en Ayudas Diagnósticas, Medellin, Colombia
- EPS y Medicina Prepagada Suramericana S.A., Medellin, Colombia
- Corresponding author
- Escobar, Juan S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-14
- Volume
- 40
- Issue
- 1
- Pages
- 54-62
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553515186
- Cited by
- 704
- References
- 40
- Citations by year
- 2026: 55 · 2025: 69 · 2024: 86 · 2023: 80 · 2022: 106 · 2021: 78 · 2020: 87 · 2019: 62 · 2018: 45 · 2017: 33 · 2016: 1
- FWCI
- 24.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- metformin, Akkermansia muciniphila, gut microbiota, short-chain fatty acids, type 2 diabetes, mucin degradation, Butyrivibrio, Bifidobacterium bifidum, Megasphaera, Prevotella, Clostridiaceae, Enterococcus casseliflavus, fecal microbiota composition, glycemic control
- MeSH terms
- Gastrointestinal Microbiome, Adolescent, Adult, Colombia, Diabetes Mellitus, Type 2, Fatty Acids, Volatile, Feces, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Mucins, RNA, Ribosomal, 16S, Case-Control Studies, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.